KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Cash from Financing Activities: 2015-2025

Historic Cash from Financing Activities for Medpace Holdings (MEDP) over the last 10 years, with Sep 2025 value amounting to $3.4 million.

  • Medpace Holdings' Cash from Financing Activities fell 45.60% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 billion, marking a year-over-year decrease of 6623.14%. This contributed to the annual value of -$154.0 million for FY2024, which is 15.68% up from last year.
  • Medpace Holdings' Cash from Financing Activities amounted to $3.4 million in Q3 2025, which was up 100.63% from -$540.6 million recorded in Q2 2025.
  • Medpace Holdings' Cash from Financing Activities' 5-year high stood at $9.1 million during Q1 2021, with a 5-year trough of -$540.6 million in Q2 2025.
  • Over the past 3 years, Medpace Holdings' median Cash from Financing Activities value was -$49.3 million (recorded in 2023), while the average stood at -$110.9 million.
  • Per our database at Business Quant, Medpace Holdings' Cash from Financing Activities spiked by 122.50% in 2021 and then crashed by 81,265.77% in 2025.
  • Medpace Holdings' Cash from Financing Activities (Quarterly) stood at $2.4 million in 2021, then plummeted by 5,493.71% to -$131.1 million in 2022, then spiked by 101.16% to $1.5 million in 2023, then tumbled by 11,170.85% to -$168.6 million in 2024, then plummeted by 45.60% to $3.4 million in 2025.
  • Its Cash from Financing Activities was $3.4 million in Q3 2025, compared to -$540.6 million in Q2 2025 and -$346.0 million in Q1 2025.